Public consultation: Intellectual property - revised framework for compulsory licensing of patents
Position Paper
25 Jul 2023
Healthcare, Intellectual property

 

Innovative companies of all sizes rely on predictable and reliable systems of intellectual property protection. Given the recent global crises, there is hardly any evidence to justify the introduction of a Compulsory Licensing (CL) system at EU-level in addition to the existing national CLs system. Thus, it is crucial that – if implemented – this legal framework is established with adequate judicial oversight, with a clear definition for what triggers the CL procedures and what constitutes as ‘crisis’ and in compliance with the TRIPS Agreement.

Related items

Position Paper
11 Nov 2025

Advancing short-term improvements to the EU Medical Devices and In Vitro Diagnostic Regulations

Healthcare
Read more
Read more about Advancing short-term improvements to the EU Medical Devices and In Vitro Diagnostic Regulations
Position Paper
7 Jul 2025

Critical Medicines Act: securing resilient and diversified supply chains for continuous access

Healthcare
Read more
Read more about Critical Medicines Act: securing resilient and diversified supply chains for continuous access
Position Paper
25 May 2025

Consultation response: Revision of the Medical Devices and In Vitro Diagnostic Medical Devices Regulations

Healthcare
Read more
Read more about Consultation response: Revision of the Medical Devices and In Vitro Diagnostic Medical Devices Regulations